Predictive value of p53 protein in ovarian cancer

European Journal of Gynaecological Oncology

Volumn 18, Issue 1, 1997, Pages 53-56

  Marchetti, M ^a,b   Chiarelli, S ^a   Mazzer, S ^a   Wabersich, J ^a   Onnis, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Clin di Ostet e Ginecol via G   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; OVARY CANCER; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY;

ADULT; AGED; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031044941     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Altavilla G., Castellan L., Wabersich J , Marchetti M., Onnis A. ''Prognostic significance of Epidermal Growth Factors Receptor (EGFR) and c-erbB-2 protein overexpression in adenocarcinoma of the uterine cervix". Eur. J. Gynaec. Oncol., 1996, 4, 267.
2. Marchetti M , Salmaso R., Polonio S., Perin D., Salviato T., Onnis A.: "Ki-67 expression in vulvar carcinoma. Preliminary results". Eur. J. Gynaec. Oncol. 1996, 5, 361.
3. Altavilla G., Marchetti M., Padovan P., Marcato E., Onnis A.: "Predictive value of Proliferative Cellular Nuclear Antigen (PCNA) and Ki-67 antigen in advanced stage serous papilliferous ovarian cancer". Eur. J. Gyanecol. Oncol., in press.
4. Leong A. S. Y.: "Immunohistochemistry of solid tumours: poorly differentiated round cell and spindle cell tumours (II)". In: 'Applied immunochemistry for the surgical pathologist'. Ed. E. Arnold, London, 1993, 96.
5. Levine A. J., Momand J., Finlay C. A.: "The p53 tumour suppressor gene". Nature, 1991, 351, 453.
6. Kern S. E., Fearon E., Tersmette K. et al.: "Allele loss in colorectal carcinoma". JAMA, 1989, 261, 3099.
7. Vogelstein B., Fearon E., Hamilton S. et al.: "Genetic alterations during colorectal-tumour development". New Engl. J. Med., 1988, 319, 525.
8. Eccles D. M., Brett L., Lessells A., Gruber L., Lane D., Steel C. M., Leonard R. C. F.: "Overexpression of the p53 protein and allele loss at 17 p13 ovarian carcinoma". Br. J. Cancer, 1992, 65, 40.
9. Findlay C., Hinds P. W., Levine A. J.: "The p53 proto-oncogene can act as a suppressor of transformation". Cell, 1989, 57, 1083.
10. Bartek J., Iggo R., Gannon J., Lane D.: "Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines". Oncogene, 1990, 5, 893.
11. Hinds P., Finlay C., Levine A. J.: "Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation". J. Virol. 1989, 63, 739.
12. Gannon J. V., Greaves R. V., Iggo R., Lane D. P.: "Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form". EMBO J., 1990, 9, 1595.
13. Lane D , Benchimol S.: "p53: oncogene or anti-oncogene?". Genes & Develop., 1990, 4, 1.
14. Bosari S., Roncalli M., Viale G. et al.: "p53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix". J. Pathol., 1993, 169, 425.
15. Kupryjanczyk J., Bell D. A., Yandell D. W., Scully R. E., Thor A. D.: "p53 expression in ovarian borderline tumors and stage I carcinomas". Am. J. Clin. Pathol., 1994, 102, 671.
16. Levesque M. A., Yu H., Zola P., Sismondi P. et al.: "Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma". Cancer, 1995, 75, 1327.
17. Bosari S., Viale G., Radaelli U., Coggi G. et al.: "p53 accumulation in ovarian carcinomas and its prognostic implications". Hum. Pathol., 1993, 24, 1175.
18. Hollstein M., Sidransky D., Vogelstein B., Harris C. C.: "p53 mutation in human cancers". Science, 1991, 253, 49.
19. Sheridan E. et al.: "p53 mutation in a series of epithelial ovarian cancer from the U. K., and its prognostic significance". Eur. J. Cancer, 1994, 30A, 1701.
20. Marks J. R., Davidoff A. M. et al.: "Overexpression and mutation of p53 in epithelial ovarian cancer". Cancer Res., 1991, 51, 2979.
21. Kurpyjanczyk J., Thor A. D. et al.: "p53 gene mutations and protein accumulation in human ovarian cancer". Proc. Natl. Acad. Sci., 1993, 90, 4961.
22. Berchuck A., Kohler M. F., Bast R C.: "Oncogenes in ovarian cancer". Hematol. Oncol. Clin. N. Am., 1992, 6, 813.
23. Hartmann L. C., Podratz K. C. et al.: "Prognostic significance of p53 immunostaining in epithelial ovarian cancer". J. Clin. Oncol., 1994, 12, 64.